We are currently experiencing some technical issues with the website. We are working on fixing these issues as soon as possible and apologise for the inconvience.

Dodávky - 565716-2019

29/11/2019    S231    Supplies - Prior information notice without call for competition - Not applicable 

United Kingdom-St Asaph: Diagnostic kits

2019/S 231-565716

Prior information notice

This notice is for prior information only

Supplies

Legal Basis:

Directive 2014/24/EU

Section I: Contracting authority

I.1)Name and addresses
Official name: NHS Wales Shared Services Partnership
Postal address: Alder House, Alder Court, St Asaph Business Park
Town: St Asaph
NUTS code: UK
Postal code: LL17 0JL
Country: United Kingdom
Contact person: Joanne Liddle
E-mail: Joanne.liddle@wales.nhs.uk
Telephone: +44 1745366820

Internet address(es):

Main address: http://www.procurement.wales.nhs.uk

Address of the buyer profile: https://www.sell2wales.gov.wales/search/Search_AuthProfile.aspx?ID=AA0221

I.1)Name and addresses
Official name: RESAH
Town: Paris
NUTS code: UKZ
Postal code: 75011
Country: United Kingdom
Contact person: Louis Potel
E-mail: Joanne.liddle@wales.nhs.uk

Internet address(es):

Main address: http://www.resah.fr/

I.2)Information about joint procurement
The contract involves joint procurement
In the case of joint procurement involving different countries, state applicable national procurement law:

Assistance Publique-Hospitaux de Paris, France

CGS UniHA, France

Societa Regionale per la Sanita, Italy

Reseau des acheteurs hospitaliers, France

I.3)Communication
Additional information can be obtained from the abovementioned address
I.4)Type of the contracting authority
Body governed by public law
I.5)Main activity
Health

Section II: Object

II.1)Scope of the procurement
II.1.1)Title:

Hospital Acquired Respiratory Infections (ICU) including Ventilator Associated Pneumonia (VAP)

II.1.2)Main CPV code
33141625
II.1.3)Type of contract
Supplies
II.1.4)Short description:

Suppliers who are able to offer any solution, either in part or in full, to diagnose VAP earlier than current culture methods; or offer solutions which may push the boundaries of innovation to prevent VAP infections are invited to register their interest.

II.1.5)Estimated total value
II.1.6)Information about lots
This contract is divided into lots: no
II.2)Description
II.2.1)Title:
II.2.2)Additional CPV code(s)
33100000
33140000
33157400
33692000
33124100
33124110
33141625
II.2.3)Place of performance
NUTS code: UKL
II.2.4)Description of the procurement:

NHS Wales Shared Services Partnership (NWSSP), hosted by Velindre NHS Trust, is publishing this prior information notice (PIN) on behalf of the European wide Innovative Procurement of Health and care Innovation (EURIPHI) project. EURIPHI is a consortium of 25 leading organisations in procurement and health care from across Europe created as a result of EU Coordination and Support Action (CSA) under Horizon 2020 ‘Innovation in Healthcare’. The aim of the project is to create a Europe-wide consortium which will define unmet needs in order to implement innovation and integrated solutions through a value-based procurement approach.

The purpose of this PIN is to open communication between the EURIPHI consortium and the market in relation to Hospital Acquired Respiratory Infections within ICU, specifically Ventilator Associated Pneumonia (VAP).

VAP is defined as pneumonia that occurs more than 48 hours after intubation. Its diagnosis is based on clinical signs and symptoms such as new infiltrate on the chest X-ray. Culture-based identification of the causative pathogen is slow and often only confirms an initial diagnosis and might guide antibiotic treatment.

Earlier detection of the presence of pathogens and their antibiotic resistance/susceptibility may assist in appropriate treatment being administered more rapidly thus positively impacting on recovery times; mortality rates; length of stay; reduction in overall costs and better antibiotic stewardship.

Further, prevention to detect VAP earlier, e.g. before suspected; or avoid VAP infections would improve perceived benefits.

Suppliers who are able to offer any solution, either in part or in full, to diagnose VAP earlier than current culture methods; or offer solutions which may push the boundaries of innovation to prevent VAP infections are invited to register their interest with NHS Wales in order to enter into open market consultation with the EURIPHI consortium.

Interested parties are requested to complete the attached short questionnaire and return to Joanne Liddle, Senior Category Manager, NWSSP by email to Joanne.liddle@wales.nhs.uk and include contact name; company name; telephone number and contact email address.

Please note publication of this PIN is a follow up to original open market consultation held by EURIPHI in Paris in 2019 as part of this project. This PIN does not guarantee a procurement exercise will follow as this will be subject to funding of individual health organisations.

II.2.14)Additional information

We wish to enter into discussions with interested suppliers during January and February 2020, interested suppliers are asked to ensure their interest is registered by no later than 10.1.2020.

II.3)Estimated date of publication of contract notice:
15/06/2020

Section IV: Procedure

IV.1)Description
IV.1.8)Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: yes

Section VI: Complementary information

VI.3)Additional information:

Note: to register your interest in this notice and obtain any additional information please visit the Sell2Wales Web Site at https://www.sell2wales.gov.wales/Search/Search_Switch.aspx?ID=97691

(WA Ref:97691)

VI.5)Date of dispatch of this notice:
26/11/2019